Dr. Daniel Rachmilewitz
#138,943
Most Influential Person Now
Dr. Daniel Rachmilewitz's AcademicInfluence.com Rankings
Dr. Daniel Rachmilewitzphilosophy Degrees
Philosophy
#7154
World Rank
#10325
Historical Rank
Logic
#4225
World Rank
#5491
Historical Rank
Download Badge
Philosophy
Why Is Dr. Daniel Rachmilewitz Influential?
(Suggest an Edit or Addition)Dr. Daniel Rachmilewitz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial (2002) (3884)
- Infliximab for induction and maintenance therapy for ulcerative colitis. (2005) (2903)
- Infliximab, azathioprine, or combination therapy for Crohn's disease. (2010) (2727)
- Infliximab maintenance therapy for fistulizing Crohn's disease. (2004) (2059)
- A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 (2000) (1189)
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. (1989) (1020)
- Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. (2004) (969)
- Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. (2004) (899)
- Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. (1978) (479)
- Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. (2009) (464)
- Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. (2005) (432)
- Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease. (1990) (395)
- Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. (1995) (375)
- Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. (2002) (357)
- Inflammatory mediators of experimental colitis in rats. (1989) (267)
- Peroxynitrite-induced rat colitis--a new model of colonic inflammation. (1993) (253)
- Femoral neck osteopenia in patients with inflammatory bowel disease (1998) (232)
- Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. (1995) (214)
- Long‐term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT‐1 and ‐2 Extension Studies (2012) (207)
- Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. (1981) (202)
- Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. (1993) (201)
- Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. (1988) (189)
- Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. (2013) (149)
- Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. (2004) (144)
- Variable Response to Probiotics in Two Models of Experimental Colitis in Rats (2002) (131)
- Metabolism of rat plasma very low density lipoprotein. I. Fate in circulation of the whole lipoprotein. (1973) (131)
- 751f One Year Data from the Sonic Study: A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab Plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy (2009) (126)
- Probiotics in inflammatory bowel disease: possible mechanisms of action (2005) (119)
- Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. (1983) (117)
- [Genetics of inflammatory bowel diseases]. (1993) (112)
- Metabolism of iodinated high density lipoproteins in the rat. I. Half-life in the circulation and uptake by organs. (1971) (110)
- Interaction of rat plasma very low density lipoprotein with lipoprotein lipase-rich (postheparin) plasma. (1975) (109)
- Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. (1993) (102)
- Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. (1991) (100)
- P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy (2008) (96)
- Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anemia. (1996) (95)
- Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. (1994) (90)
- Metabolism of rat plasma very low density lipoprotein. II. Fate in circulation of apoprotein subunits. (1973) (83)
- Ketotifen effectively prevents mucosal damage in experimental colitis. (1992) (81)
- Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. (1994) (80)
- Prostanoid synthesis by cultured gastric and duodenal mucosa: Possible role in the pathogenesis of duodenal ulcer. (1983) (77)
- Homeostatic Effects of TLR9 Signaling in Experimental Colitis (2006) (77)
- Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. (1991) (75)
- A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. (1995) (71)
- Rectal administration of nonsteroidal antiinflammatory drugs. Effect on rat gastric ulcerogenicity and prostaglandin E2 synthesis. (1990) (71)
- Octreotide effectively decreases mucosal damage in experimental colitis. (1993) (68)
- Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease. (1983) (68)
- Cyclo‐oxygenase‐2 inhibitors ameliorate the severity of experimental colitis in rats (2000) (68)
- Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation (1989) (67)
- Metabolism of iodinated high density lipoproteins in the rat. II. Autoradiographic localization in the liver. (1972) (67)
- Infliximab induction and maintenance therapy for ulcerative colitis: the ACT 2 trial (2005) (66)
- Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. (2006) (64)
- Mesalazine 4 g Daily Given as Prolonged-Release Granules Twice Daily and Four Times Daily Is at Least as Effective as Prolonged-Release Tablets Four Times Daily in Patients with Ulcerative Colitis (2001) (63)
- Early and late onset ulcerative colitis: distinct clinical features. (1985) (63)
- Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. (1995) (63)
- Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. (2004) (61)
- Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation. (1992) (61)
- Histamine and chondroitin sulfate E proteoglycan released by cultured human colonic mucosa: indication for possible presence of E mast cells. (1986) (61)
- The isolation and purification of human peripheral blood monocytes in cell suspension. (1980) (60)
- Hyperbaric oxygen: a novel modality to ameliorate experimental colitis (1998) (57)
- Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. (1993) (57)
- A novel antiulcerogenic stable radical prevents gastric mucosal lesions in rats. (1994) (56)
- Increased severity of experimental colitis in alpha5 nicotinic acetylcholine receptor subunit-deficient mice (2005) (56)
- Effect of dioctyl sodium sulfosuccinate on structure and function of rodent and human intestine. (1975) (54)
- Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. (1986) (53)
- Metabolism of iodinated very low density lipoprotein in the rat. Autoradiographic localization in the liver. (1974) (52)
- A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease (2010) (52)
- Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease (1995) (51)
- Effect of misoprostol and cimetidine on gastric cell labeling index. (1985) (51)
- Apoprotein synthesis by human duodenojejunal mucosa. (1978) (51)
- Effect of bisacodyl on the structure and function of rodent and human intestine. (1977) (50)
- Clinical trial: a multicentre, randomized, double‐blind, placebo‐controlled, dose‐finding, phase II study of subcutaneous interferon‐β‐1a in moderately active ulcerative colitis (2008) (49)
- Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. (2006) (49)
- Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats. (1995) (48)
- Effect of chronic nicotine administration on trinitrobenzene sulphonic acid‐induced colitis (1998) (45)
- Effect of cimetidine on human gastric and duodenal prostanoid synthesis. (1984) (44)
- Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease (2000) (43)
- NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis. (1993) (43)
- Phospholipases in arterial tissue. I. Sphingomyelin cholinephosphohydrolase activity in human, dog, guinea pig, rat and rabbit arteries. (1967) (42)
- Change in Erythrocyte Mean Corpuscular Volume During Combination Therapy with Azathioprine and Infliximab Is Associated with Mucosal Healing: A Post hoc Analysis from SONIC (2015) (42)
- Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. (2008) (42)
- Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats (2001) (42)
- Metabolism of iodinated high density lipoprotein subunits in the rat. 3. Comparison of the removal rate of different subunits from the circulation. (1972) (38)
- Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. (1986) (38)
- Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. (1996) (37)
- Esophageal involvement in bullous pemphigoid. (1978) (37)
- Sulphydryl blocker induced gastric damage is ameliorated by scavenging of free radicals. (1996) (36)
- Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. (2000) (35)
- Human gastric mucosal mast cells are chondroitin sulphate E-containing mast cells. (1987) (35)
- Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel. (2013) (33)
- Decreased colonic Na-K-ATPase activity in active ulcerative colitis. (1984) (33)
- Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn’s disease (1997) (33)
- Dermatomyositis associated with Crohn's disease. (1994) (33)
- An unusually high incidence of gastrointestinal obstruction by persimmon bezoars in Israeli patients after ulcer surgery (1983) (32)
- Duodenal mucosal injury with nonsteroidal antiinflammatory drugs. (1987) (32)
- Direct Determination of Colonic Nitric Oxide Level—A Sensitive Marker of Disease Activity in Ulcerative Colitis (1998) (30)
- Cimetidine and arrhythmia suppression. (1978) (30)
- IOIBD questionnaire on the clinical use of azathioprine, 6‐mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases (2000) (30)
- Effect of drugs on colonic eicosanoid accumulation in active ulcerative colitis. (1992) (30)
- Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever) (1982) (30)
- Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa. (1979) (29)
- Effect of colchicine and vinblastine on rat intestinal water transport and Na-K-ATPase activity. (1978) (28)
- Pouch ileitis--recurrence of the inflammatory bowel disease in the ileal reservoir. (1986) (28)
- Renal vasoactive mediator generation in portal hypertensive and bile duct ligated rats. (1996) (25)
- Apoprotein B in fasting and postprandial human jejunal mucosa. (1976) (25)
- Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients. (1992) (25)
- [Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center]. (2001) (24)
- Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. (1982) (23)
- Glycogenic acanthosis of the esophagus. A benign but confusing endoscopic lesion. (1980) (23)
- Nitric oxide-containing nerves in bowel segments of patients with Hirschsprung's disease. (1995) (22)
- Intrarenal nitric oxide monitoring with a Clark-type electrode: potential pitfalls. (1997) (22)
- Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis. (1990) (22)
- Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis. (1998) (22)
- Heparin and low‐molecular‐weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats (2001) (22)
- Effect of colchicine on jejunal adenylate cyclase activity, PGE2 and cAMP contents. (1980) (22)
- The effect of ketotifen on nitric oxide synthase activity (1997) (21)
- Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. (1999) (21)
- Transcobalamin II level in peripheral blood monocytes—A biochemical marker in inflammatory diseases of the bowel (1980) (21)
- Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel (1982) (21)
- Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders. (1988) (21)
- Preoperative clues to Crohn's disease in suspected, acute appendicitis. Report of 12 cases and review of the literature. (1992) (20)
- Ozone Enema: A Model of Microscopic Colitis in Rats (2001) (20)
- Effect of opiates on human colonic adenylate cyclase activity. (1983) (20)
- Crohn's disease in the elderly. (1989) (19)
- A more liberal approach to the surgical treatment of Crohn's disease. (1997) (19)
- Endoscopic Diagnosis of Duodenal Neoplasms Causing Upper Gastrointestinal Bleeding (1982) (19)
- Effect of colchicine and bisacodyl on rat intestinal transit and nitric oxide synthase activity. (1997) (19)
- The Association Between Smoking and Inflammatory Bowel Disease Among Israeli Jewish Patients (1997) (19)
- Sucralfate protection against gastrointestinal damage: possible role of prostanoids. (1986) (18)
- Crohn's disease in Ashkenazi Jews. (1990) (18)
- Ketotifen ameliorates capsaicin-augmented acetic acid-induced colitis (1995) (18)
- Comparison of human urine gastric inhibitor (HUGI) and bacterial endotoxin as inhibitors of acid secretion. (1980) (18)
- Effect of substance P on Rat gastrointestinal transit (2005) (17)
- Colonic endothelin-1 immunoreactivity in active ulcerative colitis (1992) (17)
- Effects of bisacodyl on cAMP and prostaglandin E2 contents, (Na+K) ATPase, adenyl cyclase, and phosphodiesterase activities of rat intestine (1980) (17)
- Prostaglandin E2 secretion by subsets of human peripheral blood monocytes. (1982) (16)
- Enhanced gastric and duodenal platelet-activating factor and leukotriene generation in duodenal ulcer patients. (1990) (16)
- Indomethacin‐Induced Gastroduodenal Damage Is Not Affected by Cotreatment with Ranitidine (1989) (16)
- Prevalence of inflammatory bowel disease in family members of Jewish Crohn's disease patients in Israel (1991) (15)
- PGE2 mediates the effect of pentagastrin on intestinal adenylate cyclase and Na-K-ATPase activities. (1981) (15)
- Inflammatory mediators and the pathogenesis of inflammatory bowel disease. (1992) (15)
- Recruitment of subjects for fecal occult blood screening: a comparison of two methods in Jerusalem. (1985) (15)
- An unusually high incidence of gastrointestinal obstruction by persimmon bezoars in Israeli patients after ulcer surgery. (1983) (15)
- Systemic anaphylactic reaction following lidocaine administration. (1985) (15)
- Seasonal variations in the frequency of endoscopically diagnosed duodenal ulcer in Israel. (1988) (15)
- Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation (2007) (14)
- Crohn's disease of the duodenum presented as pancreatitis due to persimmon bezoar. (1987) (14)
- Metabolic non-homogeneity of lecithin and cholesterol in aortae. (1971) (14)
- Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases. (1990) (14)
- Increased colonic adenylate cyclase activity in active ulcerative colitis. (1983) (13)
- (2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease. (1985) (13)
- No correlation between indomethacin‐induced gastroduodenal damage and inhibition of gastric prostanoid synthesis (1988) (13)
- Ketotifen--old drug, new indication: reduction of gastric mucosal injury. (1993) (13)
- Comparison of misoprostol and cimetidine in the treatment of duodenal ulcer. (1985) (13)
- Prostaglandins in small intestinal mucosa of children with celiac disease. (1984) (13)
- Abdominal wall hernias. The value of computed tomography diagnosis in the obese patient. (1994) (12)
- A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients (1986) (12)
- Prostaglandins and the pathogenesis of duodenal ulcer: no correlation with gastric mucosal PGE2 content. (1979) (12)
- Mechanisms underlying gastric antiulcerative activity of nitroxides in rats. (1999) (12)
- Somatostatin effectively prevents ethanol-and NSAID-induced gastric mucosal damage in rats (1994) (12)
- Experimental Colitis in Rats With Portal Hypertension and Liver Disease (2003) (11)
- Prostanoids in ulcerative colitis (1982) (11)
- Sulfasalazine hepatotoxicity. (1984) (11)
- Lipoprotein snthesis and secretion b cultured human intestinal mucosa (1980) (11)
- Diffuse intramural esophageal pseudodiverticulosis. (1989) (10)
- Relationship between CYP2A6 genetic polymorphism, as a marker of nicotine metabolism, and ulcerative colitis. (2011) (10)
- Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. (2008) (10)
- The role of H2‐receptor antagonists in the prevention of NSAID‐induced gastrointestinal damage (1988) (10)
- Effect of prostanoids on human intestinal Na-K-ATPase activity. (1984) (10)
- Metabolism of chenodeoxycholate by intestinal mucosa. (1976) (9)
- Severe acute pancreatitis as the presenting symptom of primary sclerosing cholangitis: treatment by endoscopic insertion of a biliary stent. (1990) (9)
- An epidemic of persimmon bezoars in Israel. (1984) (9)
- Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: colectomy analysis from ACT 1 and ACT 2: O-006. (2008) (9)
- Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle. (1999) (8)
- Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats (1999) (8)
- Prostaglandins and diarrhea (1980) (8)
- Protection by mild irritants against indomethacin-induced gastric mucosal damage in the rat: role of prostaglandin synthesis. (1986) (7)
- Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. (1990) (7)
- Evolution of Endoscopic Activity Scores in Patients With Crohn's Disease Under Azathioprine and/or Infliximab: A Post-Hoc Analysis of the Sonic Data (2011) (7)
- Effect of dioctyl sodium sulfosuccinate on cyclic AMP and prostaglandin E2 contents, and Na,K-ATPase, adenylate cyclase and phosphodiesterase activities in rat intestine. (1981) (7)
- Comparison of misoprostol and cimetidine in the treatment of gastric ulcer. (1985) (7)
- Plasma cell leukemia. Unassembled light and heavy chains in the urine. (1974) (7)
- Somatostatin release by human gastric mucosa. Studies in peptic ulcer disease and pernicious anemia. (1988) (7)
- Role of nitric oxide in gastrointestinal tract (1998) (7)
- Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis (1978) (6)
- Infliximab Reduces Colectomy in Patients with Moderate-to-Severe Ulcerative Colitis: Analysis from ACT 1 and ACT 2: 984 (2007) (6)
- New forms of treatment for inflammatory bowel disease. (1992) (6)
- NO chi generation by cultured small intestinal epithelial cells. (1995) (6)
- Possible Role of Prostanoids as Mediators in the Pathogenesis of Inflammatory Bowel Disease (1982) (6)
- Trefoil peptides: a novel modality to prevent gastric injury? (1996) (6)
- On smoking, rats, and inflammatory bowel disease. (1999) (6)
- Ketotifen and nitroxides decrease capsaicin-augmented ethanol-induced gastric damage in rats (1995) (6)
- Computer application in a gastrointestinal endoscopy unit. (1985) (6)
- Cimetidine versus antacid in critically ill patients (1981) (6)
- Cytokines and platelet-activating factor in human inflamed colonic mucosa (2005) (6)
- Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients. (1985) (6)
- Longitudinal prostaglandin E(2) generation in various organs during evolution of experimental portal hypertension. (2002) (5)
- Infliximab Induces and Maintains Mucosal Healing in Ulcerative Colitis Patients: The ACT Trials (2005) (5)
- T1139 The ACT Trials: Incremental Benefit of Second and Third Induction Doses of Infliximab in Patients with Moderately-to-Severely Active Ulcerative Colitis (UC) (2008) (5)
- Comparison of misoprostol and ranitidine in the treatment of duodenal ulcer. (1988) (5)
- Increased colonic nitric oxide level in active IBD (2008) (5)
- Ethanol inhibits triglyceride synthesis and secretion by human small intestinal mucosa. (1986) (5)
- [Endoscopic sclerotherapy for bleeding esophageal varices]. (1986) (5)
- Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats (1993) (5)
- Should we worry about gastric cancer in duodenal ulcer patients? (1985) (5)
- Assessing disease activity in Crohn's disease ‐ are we there yet? (1997) (4)
- Liver abscess at the Hadassah University during years 1967-77. (1980) (4)
- UGI bleeding in a nonalcoholic population with portal hypertension. (1980) (4)
- Effect of chronic misoprostol ingestion on rat gastric morphology and cell turnover (2004) (4)
- Association of Steroid-Free Clinical Remission and Complete Mucosal Healing at 6 Months With Clinical Outcome at 1 Year: A Post-Hoc Analysis of SONIC trial Data (2011) (4)
- Inflammatory Bowel Disease: The Asthma of the Intestine? (1996) (4)
- Towards an optimal dosage of oral-5-ASA in ulcerative colitis (1992) (4)
- Endoscopic insertion of endoprostheses in the treatment of postoperative cutaneous biliary fistula. (1987) (4)
- Pathways of lipoprotein metabolism: integration of structure, function and metabolism. (1975) (4)
- Aortic phospholipids. A biochemical, radioautographic and morphological study of phospholipid localization in normal adult aorta. (1970) (4)
- Screening for fecal occult blood in Israel. Different approaches to recruitment. (1988) (3)
- What comes first, the chicken or the egg? (1999) (3)
- Papaverine stimulation of prostaglandin E2 production by cultured rabbit gastric mucosa (1979) (3)
- 84 The Effect of Inflammatory Bowel Disease (IBD) During Pregnancy On Long-Term Health and Illness in Children of IBD Patients-a Multicenter Israeli Study (2009) (3)
- Advanced Therapy of Inflammatory Bowel Disease (2001) (3)
- Lipoprotein secretion and Apo-I synthesis by cultured human intestinal mucosa (1978) (3)
- Drug-induced bleeding of gastric leiomyoma. (1987) (3)
- Cytokines and platelet-activating factor in human inflamed colonic mucosa (2005) (3)
- Sulphasalazine and prostaglandins: An important therapeutic interaction (1981) (3)
- Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel. (1980) (3)
- [Cyclosporin for severe ulcerative colitis]. (1997) (3)
- Flufenamic acid inhibition of PGE2 production by rectal mucosa in ulcerative colitis. (1978) (3)
- A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel. (1994) (3)
- The role of eicosanoids in inflammatory bowel disease (1988) (3)
- Development of macrophage and granulocyte colonies from human peripheral blood. (1985) (3)
- Active monocytes in IBD (1980) (2)
- Cimetidine-associated mental confusion (1979) (2)
- Inflammatory mediators in inflammatory bowel disease (1998) (2)
- An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial. (1990) (2)
- Inflammatory Bowel Diseases (1982) (2)
- Ileoscopic diagnosis of terminal ileitis. (1984) (2)
- The role of platelet activating actor in acute gastric injury and its protection by sucralfate (1990) (2)
- NOx Generation by Cultured Small (1995) (2)
- Abstracts of the sixth international conference on experimental ulcer (1988) (2)
- Steroid Sparing Results in Further Improvement in Quality of Life in UC Patients in Remission: 1042 (2006) (1)
- MECHANISM OF SULPHASALAZINE ACTION IN ULCERATIVE COLITIS (1978) (1)
- Functional and morphological alterations following irradiation of isolated rat stomach: a model for estimation of radiation injury. (1988) (1)
- Decreased jejunal (Na+K)-ATPase activity in pernicious anemia (1982) (1)
- I.O.I.B.D. Questionnaire on the clinical use of Azathioprine, 6-Mercaptopurine, Cyclosporine-A and Methotrexate in the treatment of I.B.D (1996) (1)
- How have animal models of IBD contributed to advance IBD therapy? (2008) (1)
- [New therapeutic modalities in Crohn's disease]. (1999) (1)
- Investigation of field desorption mass spectral behaviour of prostaglandins for their determination in biological fluids. (1988) (1)
- The Problem Family (1949) (1)
- Functional and morphological alterations following isolated rat stomach irradiation. A model for estimation of radiation injury. (1987) (1)
- Nicotine ameliorates experimental colitis in mice deficient for the A5 neuronal nicotinic acetylcholine receptor subunit (2000) (1)
- Giant cell carcinoma of the pancreas. Report of a case with upper gastrointestinal bleeding diagnosed by endoscopic brush cytology. (1978) (1)
- Immunostimulatory DNA sequences ameliorate the extent of experimental colitis in mice and rats (2000) (1)
- Role of Platelet Activating Factor and Interleukin I in the Pathogenesis of Inflammatory Bowel Disease (1990) (1)
- (2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients. (1988) (1)
- The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators. (1994) (1)
- Role of Interferon in the Pathogenesis of Inflammatory Bowel Disease (1986) (1)
- Fat absorption and triglyceride synthesis and secretion by cultured human intestinal mucosa. (1985) (1)
- Stimulation of Mucosal Prostaglandins by Sucralfate (1995) (1)
- [Accidents and poisoning in childhood]. (1963) (1)
- Exogenous Prostaglandins and Their Analogues in Gastric Ulcer Therapy (1988) (1)
- The role of nicotine in IBD: The severity of experimental colitis in mice is dependent on the presence of the α5 neuronal nicotinic acetylcholine receptor subunit (nAChR) (2000) (1)
- [Increased incidence of malaria in Sinai and its prevention]. (1973) (1)
- Effect of misoprostol and cimetidine on gastric cell turnover (1985) (1)
- Mesalazine 5asa is as effective as sulfasalazine sz in maintenance of remission in ulcerative colitis uc (1988) (1)
- Efficacy of prostanoids in the treatment of gastric ulcer. (1987) (1)
- Uptake and Autoradiographic Localization of Very Low Density Lipoproteins in Rat Liver (1974) (1)
- Letter: An improvement in the ease of passing a hydraulic biopsy tube. (1975) (1)
- Inflammatory Bowel Diseases 1990 (1990) (1)
- P034 - The effect of inflammatory bowel disease (IBD) during pregnancy on long term health and illness in children of patients — a multicenter Israeli study (2009) (1)
- Oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease (1)
- Gastroenterological practice in Israel. (1994) (1)
- Ketotifen effectively prevents mucosal damage in expenmental colitis DETERMINATION OF MUCOSAL DAMAGE (2006) (0)
- Gastric lesions induced by antiinflammatory agents (1980) (0)
- Effects of Immunostimulatory DNA Oligonucleotides on Experimental Colitis (2002) (0)
- Laxatives and the cAMP system (2005) (0)
- Morphines inhibition of human colonic adenylate cyclase activity a possible mechanism to explain its anti diarrheal effects (1982) (0)
- Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis (1991) (0)
- P146 - The short-term efficacy and safety of adalimumab in Crohn's disease (CD) patients – a retrospective study (2009) (0)
- Antineutrophil cytoplasmic antibodies in IBD are the same in Ashkenazi and Sepharadi Jews in Israel. (1995) (0)
- [The role of emergency endoscopy in the diagnosis of upper gastrointestinal bleeding]. (1981) (0)
- Prolonged alimentation via a nasojejunal tube. (1978) (0)
- Probiotics ameliorates iodacetamide-induced colitis (1999) (0)
- NSAIDs and Gastroduodenal Lesions: How Big a Problem and How to Prevent? (1993) (0)
- [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. (1986) (0)
- Enhanced prostaglandin production by rectal mucosa in ulcerative colitis and its inhibition by sulphasalazine (1978) (0)
- [Infliximab in inflammatory bowel diseases--conference summary and suggested guidelines]. (2006) (0)
- Are individuals born as twins at a higher risk of developing Crohn's disease? (1989) (0)
- Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing (1987) (0)
- Inflammatory bowel diseases : proceedings of the International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 7-9, 1981 (1982) (0)
- Prostaglandins mediate the cathartic effects of laxatives (1980) (0)
- [Fever of unknown origin]. (1974) (0)
- Treatment of duodenal ulcer. (1985) (0)
- [HEPATIC COMA IN CHILDREN]. (1964) (0)
- 15(R)15 methyl prostaglandin E2 (Arbacet) has no effect on human gastric cell labeling index. (1988) (0)
- Inflammatory bowel diseases 1986 : proceedings of the Second International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 8-11, 1985 (1986) (0)
- Inflammatory Bowel Diseases 1986 (1986) (0)
- [Lymphoma of the intestine]. (1984) (0)
- W1150 The Short-Term Efficacy and Safety of Adalimumab in Crohn's Disease (CD) Patients- a Retrospective Study (2009) (0)
- [Current therapy of peptic ulcer]. (1986) (0)
- Effect ofcolchicine andvinblastine on ratintestinal watertransport andNa-K-ATPase activity (1978) (0)
- Gastric mucosal injury in amplified by inhibition of nitric oxide synthase activity and attenuated by nitric oxide (1995) (0)
- Colchicine and intestinal transport. (1982) (0)
- [Current surgical treatment of ulcerative colitis]. (1986) (0)
- Effect of N-methylpyridinium-2-aldoxime methane sulphonate (P2S) on rat intestinal, (Na-K)ATPase and adenyl cyclase activities. (1981) (0)
- Better experimental colitis Hyperbaric oxygen : a novel modality to ameliorate (1998) (0)
- Reply of the authors: Transcobalamin and Inflammatory Bowel Disease (1980) (0)
- Reply (1994) (0)
- Inflammatory bowel diseases--1994 : proceedings of the 72nd Falk Symposium held in Strasbourg, France, September 6-8, 1993 (1994) (0)
- Effect of nufenoxole on human colonic prostanoid synthesis, Na-K-ATPase and adenylate cyclase activities. (1984) (0)
- Prostaglandins and their role in colonic inflammation (1979) (0)
- Ketotifen — a novel approach to the prevention of damage in the gastrointestinal tract (1992) (0)
- Effect ofaminophenols (5-ASA and4-ASA) on colonic interleukin- 1generation (1992) (0)
- Therapeutic Role for Prostaglandins in Ulcerative Colitis (1988) (0)
- Comprar Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation | Dignass, A. | 9781402058882 | Springer (2007) (0)
- The role of platelet activating factor [correction of actor] in acute gastric injury and its protection by sucralfate. (1990) (0)
- [Moniliasis of the upper gastrointestinal tract]. (1980) (0)
- PSEUDOMEMBRANOUS COLITIS: IS IT INFECTIOUS? (1981) (0)
- P017 Infliximab Reduces Colectomy in Patients with Moderate-to-Severe Ulcerative Colitis: Colectomy Analysis from ACT1 and ACT2 (2008) (0)
- DIVERSE EFFECTS OF TLR SIGNALLING ON INTESTINAL INFLAMMATION (2006) (0)
- Genetics of Crohn's disease: no link with the pseudoautosomal region of the X chromosome (1994) (0)
- TUBERCULOSIS IN BEDOUIN CHILDREN. (1964) (0)
- Immunostimulatory DNA sequences ameliorate experimental colitis in mice and rats (2000) (0)
- [Lipoprotein synthesis by the human intestine]. (1978) (0)
- The role of nicotine in IBD: The severity of experimental colitis in mice is dependent on the presence of the A5 neuronal nicotinic acetylcholine receptor subunit (nAChR) (2000) (0)
- Sa1196 Prospective, Randomized, Double-Blind, Sham-Treatment Controlled Multi-Center Study to Evaluate Efficacy and Safety of Leukocytapheresis (LCAP) Using ACD-A As Anticoagulant in Patients With Steroid-Free, Active Ulcerative Colitis (2013) (0)
- Therapeutic strategy in ulcerative colitis — 2004 (2005) (0)
- [Gastric lymphoma--an infectious disease?]. (1994) (0)
- Morphine protection against ethanol-induced gastric damage - role of nitric oxide and neuropeptides (1995) (0)
- Why distinguish between ulcerative colitis and Crohn's disease? (1989) (0)
- Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects. (1997) (0)
- [Lymphoma of the colon]. (1991) (0)
- Leading article New forms of treatment for inflammatory bowel disease (0)
- [Hemorrhoids--pathogenesis and treatment]. (1984) (0)
- [A new method of bowel preparation for colonoscopy]. (1982) (0)
- Management of Crohn's disease‐new therapeutic approaches (1994) (0)
- More about intestinal lipoproteins (1979) (0)
- [Probiotics--myth or benefit?]. (1999) (0)
This paper list is powered by the following services:
